Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > GILD Gilead Sciences > Detailed Quotes

GILD Gilead Sciences

63.930
+1.300+2.08%
Close 09/28 16:00 ET
63.9300.0000.00%
Post Mkt Price 09/28 16:40 ET
High
64.370
Open
63.000
Turnover
482.63M
Low
62.710
Pre Close
62.630
Volume
7.57M
Market Cap
80.13B
P/E(TTM)
19.55
52wk High
71.472
Shares
1.25B
P/E(Static)
12.97
52wk Low
55.272
Float Cap
80.08B
Bid/Ask %
66.67%
Historical High
96.373
Shs Float
1.25B
Volume Ratio
1.05
Historical Low
0.438
Dividend TTM
2.88
Div Yield TTM
2.84
P/B
3.96
Dividend LFY
4.50%
Div Yield LFY
4.44%
Turnover Ratio
0.60%
Amplitude
2.65%
Avg Price
63.776
Lot Size
1
Float Cap
80.08B
Bid/Ask %
66.67%
Historical High
96.373
Shs Float
1.25B
Volume Ratio
1.05
Historical Low
0.438
Dividend TTM
2.88
P/B
3.96
Dividend LFY
4.50%
Turnover Ratio
0.60%
Amplitude
2.65%
Avg Price
63.776
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.
CEO: Mr. Daniel O’Day
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...